Global In-Silico Drug Discovery Market to 2031 - Focus on Product, Workflow, Technology and End-user
17 févr. 2022 05h58 HE
|
Research and Markets
Dublin, Feb. 17, 2022 (GLOBE NEWSWIRE) -- The "In-Silico Drug Discovery Market: Focus on Product, Workflow, Technology, and End User - Analysis and Forecast, 2021-2031" report has been added to...
Global ADME Toxicology Testing Market 2021-2026: Introduction of Software That Can Calculate ADME Automatically is Gaining Traction
29 déc. 2021 04h43 HE
|
Research and Markets
Dublin, Dec. 29, 2021 (GLOBE NEWSWIRE) -- The "ADME Toxicology Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...
Global Drug Discovery Informatics Market Report 2021: Discovery Workflow Segment Accounted for the Largest Share of 59.19% in 2020 - Forecast to 2028
29 sept. 2021 05h53 HE
|
Research and Markets
Dublin, Sept. 29, 2021 (GLOBE NEWSWIRE) -- The "Global Drug Discovery Informatics Market 2021-2028" report has been added to ResearchAndMarkets.com's offering. The global drug discovery informatics...
Outlook on the Display Library Technologies and Affiliated Services Global Market to 2030 - Key Industry Trends and Forecasts
09 sept. 2021 05h53 HE
|
Research and Markets
Dublin, Sept. 09, 2021 (GLOBE NEWSWIRE) -- The "Display Library Technologies and Affiliated Services Market by Type of Technology, Type of Molecule, and Key Geographical Regions, Industry Trends and...
QSAM Biosciences Announces FDA Clearance of IND for Samarium-153 DOTMP (CycloSam®), an Investigational Radiopharmaceutical for the Treatment of Bone Cancer
25 août 2021 09h00 HE
|
QSAM Biosciences Inc.
Austin, TX, Aug. 25, 2021 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next generation nuclear medicines, including Samarium-153 DOTMP (CycloSam®), for the treatment...
Global $5.62 Bn Drug Discovery Informatics Markets to 2028: Focus on Sequence Analysis, Platforms, Molecular Modeling, Docking, Clinical Trial, Data Management
18 août 2021 04h23 HE
|
Research and Markets
Dublin, Aug. 18, 2021 (GLOBE NEWSWIRE) -- The "Drug Discovery Informatics Market Share, Size, Trends, Industry Analysis Report, By Workflow; By Mode; By Services; By Regions; Segment Forecast, 2021...
Drug Patents in Development Database Service 2021: Drug Candidates in Phase I-III Clinical Trials, Clinical Trials, & API Vendors
07 mai 2021 05h38 HE
|
Research and Markets
Dublin, May 07, 2021 (GLOBE NEWSWIRE) -- The "Drug Patent Database Subscription: Drugs in Development" database has been added to ResearchAndMarkets.com's offering. This subscription was created...
Global $1.88 Billion Quantitative Structure-Activity Relationship Market to 2027: Increasing Adoption of Modeling Tools in Drug Discovery & Economic Burden of Drug Discovery
05 mai 2021 04h18 HE
|
Research and Markets
Dublin, May 05, 2021 (GLOBE NEWSWIRE) -- The "Quantitative Structure-Activity Relationship Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Application; Industry, and Geography"...
QSAM Biosciences Receives Favorable Safety Results in Study for its Leading Radiopharmaceutical Drug Candidate
21 janv. 2021 09h00 HE
|
QSAM Biosciences Inc.
Palm Beach, FL, Jan. 21, 2021 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next generation nuclear medicines for the treatment of cancer and related diseases and...
InvestorBrandNetwork Announces Gamechangers LIVE Interview with CNS Pharmaceuticals Inc. Chairman & CEO John Climaco
09 déc. 2020 09h00 HE
|
InvestorBrandNetwork (IBN)
LOS ANGELES, Dec. 09, 2020 (GLOBE NEWSWIRE) -- via InvestorWire — InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities, today announces...